Jason Lemarr Henry, MD in Pensacola, FL - Medicare Radiology

Jason Lemarr Henry, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Pensacola, Florida. His current practice location is 220 Hovey Rd, Naval Aerospace Medicine Institute, Pensacola, Florida. You can reach out to his office (for appointments etc.) via phone at (850) 452-9484.

Jason Lemarr Henry is licensed to practice in Florida (license number ME157587) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1932188174.

Contact Information

	Jason Lemarr Henry, MD
	220 Hovey Rd, Naval Aerospace Medicine Institute, Pensacola, FL 32508-1044
	(850) 452-9484
	Not Available

Physician's Profile

Full Name	Jason Lemarr Henry
Gender	Male
Speciality	Radiology - Diagnostic Radiology
Location	220 Hovey Rd, Pensacola, Florida
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1932188174
Provider Enumeration Date: 01/16/2006
Last Update Date: 03/28/2023

Medicare PECOS Information:

PECOS PAC ID: 8022256726
Enrollment ID: I20230202000537

Medical Identifiers

Medical identifiers for Jason Lemarr Henry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1932188174	NPI	-	NPPES
QD405	Other	FL	MEDICARE PTAN OHRI
114629300	Medicaid	FL
84NCY	Other	FL	BCBS
QD404	Other	FL	MEDICARE PTAN OHMG

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083A0100X	Preventive Medicine - Aerospace Medicine	0101238546 (Virginia)	Secondary
2085R0202X	Radiology - Diagnostic Radiology	ME157587 (Florida)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jason Lemarr Henry allows following entities to bill medicare on his behalf.

Entity Name	Cleveland Clinic Florida A Nonprofit Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394

News Archive

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

Inclacumab reduces damage to heart muscle during angioplasty

A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.

Researchers demonstrate simple approach to prove how classes of new drugs work

A collaborative effort by cancer researchers at Cold Spring Harbor Laboratory and chemists at Boehringer Ingelheim, a pharmaceutical firm, has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target.

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).

Entity Name	Orlando Health Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Entity Name	Ohri Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1386034346 PECOS PAC ID: 4981912169 Enrollment ID: O20151008000809

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jason Lemarr Henry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jason Lemarr Henry, MD 366 Mizzen Ln, Pensacola, FL 32507-8681 Ph: (757) 271-3494	Jason Lemarr Henry, MD 220 Hovey Rd, Naval Aerospace Medicine Institute, Pensacola, FL 32508-1044 Ph: (850) 452-9484

News Archive

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Radiology Doctors in Pensacola, FL

Dr. Christopher John Manganello, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 6000 W Highway 98, Pensacola, FL 32512 Phone: 850-505-6601
Robert Marcus Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1545 Airport Blvd, Suite 1000, Pensacola, FL 32504 Phone: 850-416-6770 Fax: 850-416-7770
Dr. Steven J Sukstorf, MD Radiology Medicare: Medicare Enrolled Practice Location: 4511 N Davis Hwy, Ste 1b, Pensacola, FL 32503 Phone: 850-484-8454
Robert M Smith Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 West Moreno Street, Pensacola, FL 32501 Phone: 850-436-4951 Fax: 850-438-6767
Dr. Donald W Farmer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5151 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-6020
Dr. William R. Balchunas, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5151 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-6020
Dr. Veronica A Carden, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1545 Airport Blvd, Suite 1000, Pensacola, FL 32504 Phone: 850-416-6700 Fax: 850-416-7770

Jason Lemarr Henry, MD - Medicare Radiology in Pensacola, FL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Inclacumab reduces damage to heart muscle during angioplasty

Researchers demonstrate simple approach to prove how classes of new drugs work

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Radiology Doctors in Pensacola, FL